Join Artur Fedorowski, MD, PhD, as he describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
A world-wide spread of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has triggered a pandemic and generated over 600 million reported cases around the globe. A substantial portion of patients who suffered Corona Virus Disease 2019 (COVID-19) have not recovered completely but continue to experience lingering symptoms for months to years. This novel clinical syndrome has been termed Long COVID or Post-acute Sequalae of COVID-19 (PASC). 
Observational studies have indicated that in about one third of cases PASC can be associated with cardiovascular (CV) autonomic dysfunction including postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, orthostatic hypotension, reflex syncope and microvascular dysfunction. The presence of CV autonomic dysfunction in PASC is important to detect since although frequently overlooked, it may be effectively treated in contrast to many other Long COVID-related symptoms. 
This webinar highlights CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
Presenters
Artur Fedorowski
Dr. Artur Fedorowski received his MD and PhD from the Wroclaw Medical University in Poland, where he received specialist training in internal medicine and cardiology. He has been an Associate Professor at Lund University since 2013 and a Fellow of the European Society of Cardiology since 2016. With over 100 publications and authorship in three books, Dr. Fedorowski has extensive experience in Cardiology and Cardiovascular Medicine. His research interests include syncope, orthostatic hypotension, cardiac arrhythmias, cardiovascular autonomic dysfunction, hypertension, biomarkers, autoimmune cardiovascular diseases and genetics of cardiovascular disease.
Sponsor
